RxDoctor Payments Data

Norman Willis, MD

Radiation Oncology · Lewiston, IDNPI 1508854290

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.8% of the total across 213 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 52 manufacturers, the largest accounting for just 7.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,469 and has fallen 86.2% since, to $203 in 2024. Among radiation oncology clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,815in general payments, 2019–2025

Across 213 payments — averaging $22.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$382
  • GSK$356
  • Merck$319
  • Regeneron Healthcare Solutions, Inc.$303
  • Seagen Inc.$270
  • Novartis$267
  • plus $3K from 46 others

What the payments were for

  • Food & beverage$4,61696%
  • Education$2004%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,815 in reported general payments places this provider in the 90th percentile of 22 radiation oncology providers in Idaho.

See all radiation oncology providers in Idaho

Medicare billing

Part B allowed, 2024
$94,293
Medicare patients
29
Services billed
401

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Lewiston

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →